Akeso, Inc. Launches Promising Phase III Study for Lung Cancer Treatment

1 month ago 30

Akeso, Inc. (($HK:9926)) announced an update on their ongoing clinical study. Akeso, Inc. has announced a new clinical study titled ‘A Multicenter, Randomized, Doub...

1. Homepage
2. Lung Cancer
3. Akeso, Inc. Launches Promising Phase III Study for Lung Cancer Treatment